Riehl melanosis
https://en.wikipedia.org/wiki/Riehl_melanosis
☆ I le 2022 Stiftung Warentest i'uga mai Siamani, o le fa'amalieina o tagata fa'atau i ModelDerm sa na'o sina maualalo ifo nai lo fa'atalanoaga telemedicine totogi. relevance score : -100.0%
References
Riehl Melanosis 32491369 NIH
Riehl melanosis e masani ona lauiloa o le pigmented contact dermatitis. O se ituaiga o pa'u e mafua mai i allergies, e masani lava ona fa'aosoina e le manogi ma isi mea e maua i mea teuteu. E ui ina fa'avasegaina o se ituaiga o dermatitis, Riehl melanosis o lo'o fa'aalia ai suiga o le pa'u i le pa'u, ma na'o ni fa'ailoga laiti o le ita. E sili atu ona taatele i tagata e pogisa pa'u pa'u. O su'esu'ega talu ai nei na su'esu'eina ai le aoga o le mid-fluence QSNY 1064-nm leisa togafitiga mo le fa'atalanoaina o le loloto o le lanu e feso'ota'i ma le Riehl melanosis. O le isi suʻesuʻega na tuʻufaʻatasia ai togafitiga eseese, e aofia ai le low-fluence 1064-nm Q-switched Nd: YAG leisa, kulimi hydroquinone, ma le oral tranexamic acid, ma iʻu ai i le faʻaleleia atili o le tele o gasegase.
Riehl melanosis (RM), commonly called pigmented contact dermatitis, is considered an acquired form of allergic contact dermatitis, typically to fragrance and other ingredients of cosmetic products. Although it is considered as a dermatitis, it presents clinically with hyperpigmentation over the face and shows pigment incontinence with minimal eczematous changes on histology. The condition is more commonly seen in dark-skinned people, causing an important psychosocial impact. A recent study showing the higher effectiveness of mid-fluence QSNY 1064-nm laser in targetting the deep pigmentation of RM has also been conducted. Another study used a combination of therapies to include low-fluence, 1064-nm, Q-switched Nd: YAG laser, hydroquinone cream, and oral tranexamic acid, with the majority of patients experiencing significant improvement.
Research Advances in the Treatment of Riehl’s Melanosis 37168093 NIH
Riehl's melanosis o se ituaiga o ma'i o le pa'u e mafua mai i le fa'afeso'ota'i ma nisi o allergens ma a'afia i le la. E o'o atu ai i le vave, fa'asolosolo enaena-enaena pigmentation o le pa'u, lea e mafai ona matua a'afia ai tagata mama'i i le mafaufau ma le tino. E ui o le mafuaaga tonu o le Riehl's melanosis e le o iloa, o suʻesuʻega o loʻo i ai nei o loʻo faʻaalia ai se fesoʻotaʻiga malosi ma le faʻaalia o le allergen. Mo le togafitiga, ua uma ona fa'ata'ita'iina vaila'au fa'aleaganu'u ma le laser, e masani lava fa'atasi ma le fa'aogaina o vaila'au fa'apipi'i e fa'aoga i le pa'u. Leisa togafitiga, aemaise lava le fa'aogaina o le Q-switched Nd:YAG leisa, ua fa'aalia i'uga lelei mo le togafitia o le Riehl's melanosis. O le tuʻufaʻatasia o togafitiga eseese e taʻitaʻia ai iʻuga lelei.
Riehl's melanosis (RM) is a contact photodermatitis, with fast progressive gray-brown skin pigmentation as the main manifestation, which can seriously affect the psychology and physiology of patients. Currently, although the etiological factors of Riehl's melanosis is still be unknown, the existing literature proves clearly the cause of it is related to the contacting with suspected allergens. For decades, there has been no standard method for the treatment of RM, but with both conventional drug therapy and laser therapy having been attempted. Topical application of bleaching agents is mainly used as an auxiliary treatment modality. The laser treatment modality remains a hot spot, among which Q-switched Nd:YAG laser is well received for RM. Positive outcomes have been achieved by the combined treatment modalities attempted in recent years also achieve positive outcomes.